Distribuzione geografica
Continente #
NA - Nord America 3268
EU - Europa 2790
AS - Asia 1141
OC - Oceania 4
Totale 7203
Nazione #
US - Stati Uniti d'America 3263
IE - Irlanda 1655
CN - Cina 1109
SE - Svezia 575
IT - Italia 334
PL - Polonia 92
DE - Germania 55
BE - Belgio 24
VN - Vietnam 14
AT - Austria 12
FR - Francia 11
GB - Regno Unito 9
RU - Federazione Russa 8
IN - India 7
CA - Canada 5
FI - Finlandia 5
AU - Australia 4
NL - Olanda 4
UA - Ucraina 3
BG - Bulgaria 2
JP - Giappone 2
KR - Corea 2
PH - Filippine 2
TW - Taiwan 2
IQ - Iraq 1
IR - Iran 1
RO - Romania 1
TH - Thailandia 1
Totale 7203
Città #
Dublin 1655
Chandler 541
Dearborn 509
Nyköping 399
Princeton 327
Beijing 309
Jacksonville 266
Des Moines 232
San Mateo 224
Cambridge 219
Medford 168
Messina 152
Jinan 116
Shenyang 109
Warsaw 92
Nanjing 61
Wilmington 59
Ningbo 57
Tianjin 57
Zhengzhou 50
Ann Arbor 48
Hebei 47
Bremen 46
Haikou 39
Lanzhou 38
Nanchang 38
Hangzhou 31
Taizhou 28
Brussels 24
Fuzhou 19
Guangzhou 18
Jiaxing 17
Changsha 15
Dong Ket 14
Rome 14
Norwalk 13
Falls Church 11
Vienna 8
Saint Petersburg 7
Ashburn 5
Lancaster 5
New Delhi 5
Ottawa 5
Taiyuan 5
Fairfield 4
Hefei 4
Houston 4
Kunming 4
Mineo 4
Mountain View 4
Padova 4
Redmond 4
San Giuliano Terme 4
Aci Bonaccorsi 3
Adelaide 3
Boardman 3
Cagliari 3
Canicattì 3
Capannori 3
Iowa City 3
Lesignano de' Bagni 3
Milan 3
Piazza Armerina 3
Redwood City 3
Speyer 3
Turin 3
Wuhan 3
Brooklyn 2
Catania 2
Fort Worth 2
Glasgow 2
Graz 2
Helsinki 2
Legnano 2
Montreuil 2
Paterno 2
Peschiera 2
Presezzo 2
Saint-Fons 2
Seattle 2
Woodbridge 2
Acerra 1
Anguillara 1
Augusta 1
Berlin 1
Bianco 1
Bologna 1
Boydton 1
Brindisi 1
Caserta 1
Chicago 1
Chongqing 1
Fiumefreddo Di Sicilia 1
Hunedoara 1
Kharkov 1
Leawood 1
Marano Di Napoli 1
Mascalucia 1
Modica 1
Nanning 1
Totale 6227
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 115
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 84
Molecular links between COPD and lung cancer: new targets for drug discovery? 73
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 66
Functional role of inflammasome activation in a subset of obese nonsmoking patients with severe asthma 64
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. 62
Asthma under/misdiagnosis in primary care setting: An observational community-based study in Italy 60
Polmonite interstiziale fibrosante da amiodarone 59
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 57
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 56
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 56
Autoimmunity and COPD: Clinical Implications 50
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 48
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 47
Bacterial infections in the lungs of patients with systemic autoimmune diseases 47
Allergen Responses Modified by a GATA3 DNAzyme 46
Controllo della broncopneumopatia cronica ostruttiva in Italia 45
Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD 45
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto. 44
Asma. 44
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? 44
OXIDANTS AND ANTIOXIDANTS | Antioxidants, Nonenzymatic 44
Posttranscriptional Gene Regulatory Networks in Chronic Airway Inflammatory Diseases: In silico Mapping of RNA-Binding Protein Expression in Airway Epithelium 44
Role of the mucins in pathogenesis of COPD: implications for therapy 43
Activation of NF-kappaB transcription factor in asthma death 42
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 42
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 42
Rischio di polmonite durante trattamenti regolari a lungo termine con glucocorticoidi inalatori nei pazienti con BPCO stabile: Revisione sistematica della letteratura 41
Transcription inhibitors and inflammatory cell activity 41
Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study 41
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 40
The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide 40
Commentary on "Major Complications Associated with Conventional Transbronchial Needle Aspiration" 40
Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease 39
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 39
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 38
Asma. 38
Asthma death. 38
Asthma: a chronic infectious disease? 38
Trattamento personalizzato dei pazienti con BPCO in fase stabile [Personalised treatment of stable COPD patients] 37
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. 37
Anatomia e fisiologia clinica della pleura. 37
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 37
Anti-inflammatory treatments for asthma: past, present, future. 36
Airway obstruction in chronic obstructive pulmonary disease. 36
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 36
Interferonopathy: A potential link between innate immunity and autoimmunity in the pathogenesis of COPD 36
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. 35
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 35
An unusual cause of chest pain 35
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 35
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 34
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD 34
A case of fibrosing interstitial pneumonia 34
Epithelial Posttranscriptional Gene Regulatory Networks In Chronic Airway Inflammation: In Silico Mapping Of RNA-Binding Protein Expression 33
COPD immunopathology 33
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper 33
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 33
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 32
New drugs under development for COPD 32
FN3K expression in COPD: A potential comorbidity factor for cardiovascular disease 32
Stato dell’arte degli antileucotrienici nella terapia dell’asma. 31
Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature 31
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 31
Methotrexate in the treatment of systemic glucocorticoid dependent severe persistent astma: a word of caution. 30
Corticosteroid resistance in asthma: Cellular and molecular mechanisms 30
Gli antagonisti dei leucotrieni: nuove speranze nella terapia dell'asma? 29
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 29
Studio clinico-epidemiologico sulle neoplasie polmonari maligne. Confronto tra 2 coorti di pazienti nei quinquenni 1981-5 e 1991-5. 29
La scoperta dell’ossido nitrico endogeno ha aperto nuove prospettive terapeutiche nella patologia polmonare dell’adulto? 29
Polmoniti da parassiti 29
null 29
Versamento ed empiema pleurico parapneumonico nell’adulto 29
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 29
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 29
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 28
Targeting Th2 cells in asthmatic airways 28
Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs 28
Breaking news: DNA damage and repair pathways in COPD and implications for pathogenesis and treatment 28
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 28
Birbeck granules: contribution to the comprehension of intracytoplasmic evolution. 28
La teofillina nella BPCO: nuove prospettive (3° parte). 27
Donna non fumatrice con asma bronchiale difficile da controllare. 27
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 27
Pulmonary vasculitis: classification, clinical features and management. 27
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 27
Ruolo dei beta2 agonisti a lunga durata di azione nella gestione del paziente asmatico. 26
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 25
Nuove linee guida internazionali per la terapia farmacologica dell’asma. 25
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive. 25
Le linee guida vengono seguite? 25
Kinase targets and inhibitors for the treatment of airway inflammatory diseases: the next Generation of drugs for severe asthma and COPD?. 25
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 25
Gender and respiratory infections. 25
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. 24
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 24
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 24
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 24
Delivery systems e protocollo di Montreal. 24
Totale 3792
Categoria #
all - tutte 21083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21083

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018228 0000 00 00 002226
2018/201963 021811 22 55 6057
2019/2020924 7053 3443 11226 341918515
2020/20211371 191971021 2778 1491 83594426
2021/20221672 5655273 2713 18187 2173336586
2022/20233114 368189104152 134184 35102 181111240
Totale 7669